194 related articles for article (PubMed ID: 11491496)
21. [Diagnostic significance of Th1/Th2 cytokine pattern in childhood hemophagocytic lymphohistiocytosis].
Xu XJ; Tang YM; Zhao N; Song H; Yang SL; Shi SW; Xu WQ; Pan BH; Zhang LY; Mao JQ; Shen HP; Gu ME; Xia J
Zhonghua Er Ke Za Zhi; 2011 Sep; 49(9):685-9. PubMed ID: 22176904
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal gammopathy related to Sjögren syndrome: a key marker of disease prognosis and outcomes.
Brito-Zerón P; Retamozo S; Gandía M; Akasbi M; Pérez-De-Lis M; Diaz-Lagares C; Bosch X; Bové A; Pérez-Alvarez R; Soto-Cárdenas MJ; Sisó A; Ramos-Casals M
J Autoimmun; 2012 Aug; 39(1-2):43-8. PubMed ID: 22297146
[TBL] [Abstract][Full Text] [Related]
23. Synergistic immunosuppression by candida in HIV infection: a cytokine based analysis.
Bajaj JS; Singh A; Aggarwal SK; Chattopadhya D; Baveja UK
J Commun Dis; 2000 Mar; 32(1):1-9. PubMed ID: 11186879
[TBL] [Abstract][Full Text] [Related]
24. Influence of clinical and immunological parameters on the health-related quality of life of patients with primary Sjögren's syndrome.
Belenguer R; Ramos-Casals M; Brito-Zerón P; del Pino J; Sentís J; Aguiló S; Font J
Clin Exp Rheumatol; 2005; 23(3):351-6. PubMed ID: 15971423
[TBL] [Abstract][Full Text] [Related]
25. [Primary Sjögren's syndrome: clinical and immunologic study of 80 patients].
Ramos M; Cervera R; García-Carrasco M; Miret C; Muñoz FJ; Espinosa G; Font J; Ingelmo M
Med Clin (Barc); 1997 May; 108(17):652-7. PubMed ID: 9312582
[TBL] [Abstract][Full Text] [Related]
26. Disproportion of helper T cell subsets in peripheral blood of patients with primary Sjögren's syndrome.
Kohriyama K; Katayama Y
Autoimmunity; 2000; 32(1):67-72. PubMed ID: 10958177
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-13 in autoimmune rheumatic diseases: relationship with the autoantibody profile.
Spadaro A; Rinaldi T; Riccieri V; Taccari E; Valesini G
Clin Exp Rheumatol; 2002; 20(2):213-6. PubMed ID: 12051401
[TBL] [Abstract][Full Text] [Related]
28. Divergent effect of cyclosporine on Th1/Th2 type cytokines in patients with severe, refractory rheumatoid arthritis.
Kim WU; Cho ML; Kim SI; Yoo WH; Lee SS; Joo YS; Min JK; Hong YS; Lee SH; Park SH; Cho CS; Kim HY
J Rheumatol; 2000 Feb; 27(2):324-31. PubMed ID: 10685792
[TBL] [Abstract][Full Text] [Related]
29. Clinical efficacy of leflunomide in primary Sjogren's syndrome is associated with regulation of T-cell activity and upregulation of IL-7 receptor α expression.
Bikker A; van Woerkom JM; Kruize AA; van der Wurff-Jacobs KM; Bijlsma JW; Lafeber FP; van Roon JA
Ann Rheum Dis; 2012 Dec; 71(12):1934-41. PubMed ID: 22563027
[TBL] [Abstract][Full Text] [Related]
30. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia/lymphoma: high interleukin-5 and -10 levels are significant unfavorable prognostic factors.
Inagaki A; Ishida T; Ishii T; Komatsu H; Iida S; Ding J; Yonekura K; Takeuchi S; Takatsuka Y; Utsunomiya A; Ueda R
Int J Cancer; 2006 Jun; 118(12):3054-61. PubMed ID: 16425276
[TBL] [Abstract][Full Text] [Related]
32. Role of Salivary Immune Parameters in Patients With Primary Sjögren's Syndrome.
Hung YH; Lee YH; Chen PP; Lin YZ; Lin CH; Yen JH
Ann Lab Med; 2019 Jan; 39(1):76-80. PubMed ID: 30215233
[TBL] [Abstract][Full Text] [Related]
33. Increased serum levels of interleukin 10 in Sjögren's syndrome; correlation with increased IgG1.
Perrier S; Serre AF; Dubost JJ; Beaujon G; Plazonnet MP; Albuisson E; Sauvezie B
J Rheumatol; 2000 Apr; 27(4):935-9. PubMed ID: 10782819
[TBL] [Abstract][Full Text] [Related]
34. Immunological alterations in newly diagnosed primary Sjögren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines.
Szodoray P; Gal I; Barath S; Aleksza M; Horvath IF; Gergely P; Szegedi G; Nakken B; Zeher M
Scand J Rheumatol; 2008; 37(3):205-12. PubMed ID: 18465456
[TBL] [Abstract][Full Text] [Related]
35. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome.
Ramos-Casals M; Brito-Zerón P; Yagüe J; Akasbi M; Bautista R; Ruano M; Claver G; Gil V; Font J
Rheumatology (Oxford); 2005 Jan; 44(1):89-94. PubMed ID: 15381790
[TBL] [Abstract][Full Text] [Related]
36. Interleukin 10 (IL-10) influences autoimmune response in primary Sjögren's syndrome and is linked to IL-10 gene polymorphism.
Anaya JM; Correa PA; Herrera M; Eskdale J; Gallagher G
J Rheumatol; 2002 Sep; 29(9):1874-6. PubMed ID: 12233881
[TBL] [Abstract][Full Text] [Related]
37. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome.
Chen C; Liang Y; Zhang Z; Zhang Z; Yang Z
Int Immunopharmacol; 2020 Nov; 88():106878. PubMed ID: 32791244
[TBL] [Abstract][Full Text] [Related]
38. Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection.
Fan XG; Liu WE; Li CZ; Wang ZC; Luo LX; Tan DM; Hu GL; Zhang Z
Mediators Inflamm; 1998; 7(4):295-7. PubMed ID: 9792341
[TBL] [Abstract][Full Text] [Related]
39. s-IgA and cytokine levels in whole saliva of Sjögren's syndrome patients before and after oral pilocarpine hydrochloride administration: a pilot study.
Rhodus N; Dahmer L; Lindemann K; Rudney J; Mathur A; Bereuter J
Clin Oral Investig; 1998 Dec; 2(4):191-6. PubMed ID: 10388393
[TBL] [Abstract][Full Text] [Related]
40. High prevalence of serum metabolic alterations in primary Sjögren's syndrome: influence on clinical and immunological expression.
Ramos-Casals M; Brito-Zerón P; Sisó A; Vargas A; Ros E; Bove A; Belenguer R; Plaza J; Benavent J; Font J
J Rheumatol; 2007 Apr; 34(4):754-61. PubMed ID: 17309127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
